Filing Flows › Eton Pharmaceuticals (ETON) › Gross margin
Eton Pharmaceuticals (ETON) gross margin by quarter
Eton Pharmaceuticals' gross margin was 76.5% in Q3 2026 (third quarter 2026), +8.9 pts from Q2 2026. Over the last 4 quarters it ranged from 60.7% (Q1 2026) to 76.5% (Q3 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 76.5% | +8.9 pts | — |
| Q2 2026 | 67.6% | +6.9 pts | — |
| Q1 2026 | 60.7% | -0.8 pts | — |
| Q4 2025 | 61.6% | — | — |
Q3 2026 at a glance
Eton Pharmaceuticals, Q3 2026: revenue $57.9M (+158% year over year), operating margin 39.7%, net earnings $35.2M, operating cash flow $35.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Eton Pharmaceuticals' gross margin?
Eton Pharmaceuticals' gross margin was 76.5% in Q3 2026 (third quarter 2026), +8.9 pts from Q2 2026.
How has Eton Pharmaceuticals' gross margin changed?
Over the last 4 quarters it ranged from 60.7% (Q1 2026) to 76.5% (Q3 2026).